We’re #hiring! join us in our ambitious goal to #erasecancer. Contact Guevara Rowand or Raj Advani for more information.
Erasca, Inc.
生物技术研究
San Diego，California 6,334 位关注者
Our mission at Erasca is embedded in our name: To erase cancer.
关于我们
Our mission at Erasca is embedded in our name: To erase cancer. Energized by recent scientific discoveries and advances in drugging various biological drivers of cancer, we are committed to solving oncology’s hardest problems. We have assembled a proven team and joined forces with world-class collaborators who embrace our ambitious goals. In addition to our initial programs for undisclosed cancer targets, we seek to expand our pipeline through partnerships with academic scientists and biopharmaceutical companies who have revealed potential new mechanisms for precision oncology. Importantly, Erasca isn’t tied to one form of drug or any singular approach to treating cancer. By keeping an open mind about what is possible, we believe we will achieve the greatest results for patients everywhere.
- 网站
-
https://www.erasca.com
Erasca, Inc.的外部链接
- 所属行业
- 生物技术研究
- 规模
- 51-200 人
- 总部
- San Diego，California
- 类型
- 上市公司
- 创立
- 2018
地点
-
主要
获取路线
10835 Road to the Cure
Suite 140
US，California，San Diego，92121
Erasca, Inc.员工
动态
-
We are #hiring! Join us in our ambitious goal to #erasecancer. Contact Guevara Rowand or Chris Rupsa for more information.
-
We are #hiring a head of Biostatistics! Join us in our audacious goal to #erasecancer. Contact Matthew Guo or Guevara Rowand for more information.
-
We are #hiring in Clinical Operations! Join us in our audacious goal to #erasecancer. Contact Amy (Grekowicz) Parker, MPH or Guevara Rowand for more information.
Director Clinical Operations - Erasca
https://www.erasca.com
-
We are #hiring in Drug Safety! Join us in our ambitious goal to #erasecancer. Contact Hina Patel or Guevara Rowand for more information.
-
We are pleased to announce that we have initiated our SEACRAFT-2 pivotal Phase 3 trial evaluating naporafenib plus trametinib in patients with NRAS-mutant melanoma! Click the link below for more details about this exciting update. #Erasca #Erasecancer https://lnkd.in/gs2btYgz
Erasca Initiates SEACRAFT-2 Pivotal Phase 3 Trial Evaluating Naporafenib Plus Trametinib in Patients with NRAS-Mutant Melanoma – Erasca Inc
investors.erasca.com
-
Happy Administrative Professionals Day to our incredible admin team who keep our offices running seamlessly to ensure the success of our teams! Thank you for your hard work, your positivity, and your unwavering commitment to excellence. ?Your dedication and support do not go unnoticed. We are grateful for all that you do! Elisabeth Lopez, J. Alonzo C., Jen Roberts #AdministrativeProfessionalsDay #Thankyou #Erasca #Erasecancer
-
-
As we reflect at the end of #WomensHistoryMonth, we want to take a moment to celebrate the tremendous women in our Finance and Accounting department here at #Erasca. From meticulously managing our financial resources to ensuring compliance and accuracy, their dedication and expertise are instrumental in driving our vision forward. We are truly fortunate to have them as integral members of our team. Take a look at what motivated them to join our mission to #erasecancer.?
-